Serum Institute of India (SII) has said that the World Health Organization (WHO) has approved the world's second malaria vaccine.

WHO has given this approval on the basis of pre-clinical and clinical trial data of the vaccine. In trials, this vaccine was found to be quite effective in four countries.

According to the news of news agency PTI, SII has said in a statement that it has become the second vaccine in the world to get the approval of the World Health Organization to protect children from malaria.

This R21/Matrix-M malaria vaccine has been developed by SII in collaboration with Oxford University.

SII has said that it has made arrangements to produce 10 crore doses of the vaccine every year and this production will double in the next two years.

Currently this vaccine is being used in Ghana, Nigeria and Burkina Faso. But now after the approval of the World Health Organization, it can be used all over the world.

(Click here for Android APP of IBTN. You can follow us on facebook and Twitter)

Share This News

About sharing